Status: Recruiting
ColoSense Post-Approval Study
The post-approval study (PAS) described here will supplement existing data generated in the CRC-PREVENT clinical trial. The primary outcomes of this supplemental study will include: clinical sensitivity, clinical specificity, positive predictive value (PPV), and negative predictive value (NPV) of ColoSense.
Participants needed: 12,500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Geneoscopy, Inc.Updated: Nov 21, 2025Locations: 1
Eligibility criteria
Subject is male or female, ≥45 years of age (subjects aged 18-45 can be enrolled... [+3]
Subject had any precancerous findings on most recent colonoscopy. This does not... [+13]